Aleksander Lukasiewicz
Research Subjects
Aleksander Lukasiewicz has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Tomasz Drewa
Department of Urology and Andrology, Collegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland
5 shared publications Stanisław Molski
3 shared publicationsWojciech Lichota
Department of Vascular Surgery, Regional Specialty Hospital, Grudziadz, Poland
2 shared publications- Andrzej Kotela
Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, Woycickiego 1/3, 01-938 Warsaw, Poland
1 shared publication Andrzej M.D. Marszalek
Grudziadz, Torun, and Bydgoszcz, Poland
1 shared publicationAndrzej Marszalek
Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet mikołaja Kopernika w Toruniu
1 shared publication
Latest Publications
- 21 October 2021
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 27 (2) , 41-48
The treatment of complex femoropopliteal atherosclerotic lesions- conclusions from the unselected patients cohort.
Background: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report summarizes the current experience in the treatment of complex femoropopliteal lesions in the author's center. Material and methods: This is a retrospective, observational cohort study of patients with complex femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: 201 patients were included. 130 patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p<0.001), shorter (25 vs 30 cm, p<0.02), TASC C lesions (63.1% vs 40.3%, p<0.003). Complications were more common in FB group (26.9% vs 13.8%, p<0.03). Reinterventions were similar. The postoperative stay was shorter (1 vs. 6 days, p<0.001). . Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular pocedure. The limb salvage at 3 years was highest in the ET group (94.1% ) and the difference was significant (p<0.04, and p<0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome. Background: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report summarizes the current experience in the treatment of complex femoropopliteal lesions in the author's center. Material and methods: This is a retrospective, observational cohort study of patients with complex femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: 201 patients were included. 130 patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p<0.001), shorter (25 vs 30 cm, p<0.02), TASC C lesions (63.1% vs 40.3%, p<0.003). Complications were more common in FB group (26.9% vs 13.8%, p<0.03). Reinterventions were similar. The postoperative stay was shorter (1 vs. 6 days, p<0.001). . Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular pocedure. The limb salvage at 3 years was highest in the ET group (94.1% ) and the difference was significant (p<0.04, and p<0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome.
- 21 October 2021
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 27 (2) , 41-48
The treatment of complex femoropopliteal atherosclerotic lesions- conclusions from the unselected patients cohort.
Background: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report summarizes the current experience in the treatment of complex femoropopliteal lesions in the author's center. Material and methods: This is a retrospective, observational cohort study of patients with complex femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: 201 patients were included. 130 patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p<0.001), shorter (25 vs 30 cm, p<0.02), TASC C lesions (63.1% vs 40.3%, p<0.003). Complications were more common in FB group (26.9% vs 13.8%, p<0.03). Reinterventions were similar. The postoperative stay was shorter (1 vs. 6 days, p<0.001). . Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular pocedure. The limb salvage at 3 years was highest in the ET group (94.1% ) and the difference was significant (p<0.04, and p<0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome. Background: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report summarizes the current experience in the treatment of complex femoropopliteal lesions in the author's center. Material and methods: This is a retrospective, observational cohort study of patients with complex femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: 201 patients were included. 130 patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p<0.001), shorter (25 vs 30 cm, p<0.02), TASC C lesions (63.1% vs 40.3%, p<0.003). Complications were more common in FB group (26.9% vs 13.8%, p<0.03). Reinterventions were similar. The postoperative stay was shorter (1 vs. 6 days, p<0.001). . Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular pocedure. The limb salvage at 3 years was highest in the ET group (94.1% ) and the difference was significant (p<0.04, and p<0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome.
- Open Access
- 16 May 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5) , 1501
Contemporary Management of Acute Lower Limb Ischemia: Determinants of Treatment Choice
The role of endovascular procedures in the treatment of acute lower limb ischemia (ALI) is expanding. For treatment, the choice between surgical or endovascular is still debated. The aim of this study was to identify factors that determine the selection of treatment. This study included 307 ALI patients (209 with thrombosis). Patient details, factors affecting the procedure choice, and outcomes were analyzed. The majority of patients were operated on (52.4%). Surgery was more frequent in embolic patients with embolus (odds ratio (OR) 33.85; 95% confidence interval (CI) 6.22–184.19, p < 0.0001), severe ischemia (OR 1.79; 95% CI 1.2–2.66, p = 0.0041), and active cancer (OR 4.99; 95% CI 1.26–19.72, p = 0.02). Tibial arteries involvement was negatively related to surgery (OR 0.25; 95% CI 0.06–0.95, p = 0.04). The complications and amputation rates were comparable. Reinterventions were more common in the endovascular group (19 (20.2%) vs. 17 (8.9%), p = 0.007). The six-month mortality was higher in the operated patients (12.6% vs. 3.2%, respectively, p = 0.001). The determinants of the treatment path are ischemia severity, concurrent cancer, embolus, and peripheral lesion location. Modification of the Rutherford acute lower limb ischemia classification is required to improve the decision-making in patients with profound ischemia.
- 16 May 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5) , 1501
Open AccessContemporary Management of Acute Lower Limb Ischemia: Determinants of Treatment Choice
The role of endovascular procedures in the treatment of acute lower limb ischemia (ALI) is expanding. For treatment, the choice between surgical or endovascular is still debated. The aim of this study was to identify factors that determine the selection of treatment. This study included 307 ALI patients (209 with thrombosis). Patient details, factors affecting the procedure choice, and outcomes were analyzed. The majority of patients were operated on (52.4%). Surgery was more frequent in embolic patients with embolus (odds ratio (OR) 33.85; 95% confidence interval (CI) 6.22–184.19, p < 0.0001), severe ischemia (OR 1.79; 95% CI 1.2–2.66, p = 0.0041), and active cancer (OR 4.99; 95% CI 1.26–19.72, p = 0.02). Tibial arteries involvement was negatively related to surgery (OR 0.25; 95% CI 0.06–0.95, p = 0.04). The complications and amputation rates were comparable. Reinterventions were more common in the endovascular group (19 (20.2%) vs. 17 (8.9%), p = 0.007). The six-month mortality was higher in the operated patients (12.6% vs. 3.2%, respectively, p = 0.001). The determinants of the treatment path are ischemia severity, concurrent cancer, embolus, and peripheral lesion location. Modification of the Rutherford acute lower limb ischemia classification is required to improve the decision-making in patients with profound ischemia.
- 1 March 2020
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 61 (2) , 200-207
Catheter-directed thrombolysis is not limited to acute limb ischemia treatment: experience from a division of vascular surgery
BACKGROUND: Thrombolytic treatment has many potential indications in the era of modem vascular surgery. We aimed to analyze the contemporary experience in the catheter-directed, intraarterial thrombolysis in different clinical scenarios. METHODS: The available data of 121 patients with different types (acute, subacute, complications of vascular procedures) of lower limb ischemia treated by means of the intraarterial, catheter-directed thrombolysis between November 2011 and December 2016 were retrospectively analyzed. The basic treatment protocol, utilized in 92% of patients, was a catheter-directed infusion of 40 mg of alteplase within 3.5 hours. Pre- and intraprocedural factors (indications, demographic details, comorbidities, the dose of alteplase utilized, underlying lesions procedures), as well as postoperative outcomes (lysis grade, death, complications, reinterventions, and limb loss after 1-month observation), were analyzed. RESULTS: Successful thrombolysis was achieved in 76.1% (92 of 121) patients. The success rate was similar for acute, subacute limb ischemia and thrombotic complications of vascular procedures. Around 67.8% of patients (N.=82) had procedures to correct underlying lesions performed. Overall complication rate was 28.1%, but the major bleeding was observed in only 5% (6 patients). Neither intracranial bleeding nor gastrointestinal bleeding occurred. No mortality, 1.7% reintervention rate and 10.7% amputation rate were recorded during one-month follow-up. CONCLUSIONS: Accelerated intraarterial thrombolysis is an effective measure in the treatment of acute, sub-acute limb ischemia as well as thromboembolic complications of vascular procedures. It carries a low risk of major bleeding. The location of thrombus in the crural arteries adversely affects the treatment results. Atrial fibrillation increases the risk of amputation while complete thrombus lysis is protective.
- 1 March 2020
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 61 (2) , 200-207
Catheter-directed thrombolysis is not limited to acute limb ischemia treatment: experience from a division of vascular surgery
BACKGROUND: Thrombolytic treatment has many potential indications in the era of modem vascular surgery. We aimed to analyze the contemporary experience in the catheter-directed, intraarterial thrombolysis in different clinical scenarios. METHODS: The available data of 121 patients with different types (acute, subacute, complications of vascular procedures) of lower limb ischemia treated by means of the intraarterial, catheter-directed thrombolysis between November 2011 and December 2016 were retrospectively analyzed. The basic treatment protocol, utilized in 92% of patients, was a catheter-directed infusion of 40 mg of alteplase within 3.5 hours. Pre- and intraprocedural factors (indications, demographic details, comorbidities, the dose of alteplase utilized, underlying lesions procedures), as well as postoperative outcomes (lysis grade, death, complications, reinterventions, and limb loss after 1-month observation), were analyzed. RESULTS: Successful thrombolysis was achieved in 76.1% (92 of 121) patients. The success rate was similar for acute, subacute limb ischemia and thrombotic complications of vascular procedures. Around 67.8% of patients (N.=82) had procedures to correct underlying lesions performed. Overall complication rate was 28.1%, but the major bleeding was observed in only 5% (6 patients). Neither intracranial bleeding nor gastrointestinal bleeding occurred. No mortality, 1.7% reintervention rate and 10.7% amputation rate were recorded during one-month follow-up. CONCLUSIONS: Accelerated intraarterial thrombolysis is an effective measure in the treatment of acute, sub-acute limb ischemia as well as thromboembolic complications of vascular procedures. It carries a low risk of major bleeding. The location of thrombus in the crural arteries adversely affects the treatment results. Atrial fibrillation increases the risk of amputation while complete thrombus lysis is protective.
- Open Access
- 1 January 2018
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 71 (3) , 338-341
Symptomatic hilar renal artery aneurysm mimicking renal colic - a word of caution
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- 1 January 2018
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 71 (3) , 338-341
Open AccessSymptomatic hilar renal artery aneurysm mimicking renal colic - a word of caution
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- Open Access
- 29 September 2016
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 22 (1) , 16-19
Spontaneous rupture of abdominal aorta — an unusual manifestation of an idiopathic cystic medial necrosis (Gsell-Erdheim syndrome) and literature overview
In this report, a case of a male, 40-year-old patient who suffered from spontaneous rupture of undilated abdominal aorta, a manifestation of idiopathic cystic media necrosis (Gsell-Erdheim syndrome), is presented. Spontaneous ruptures of medium-to-large arteries observed in this syndrome are a consequence of elastic fibres degeneration and glucose-amino-glycans (GAG) depositions in the arterial media. Gsell-Erdheim syndrome is also observed in a large portion of spontaneous aortic dissections. Histopathological criteria for the diagnosis of this disease, as well as clinical implications for current treatment, especially endovascular procedures in the aortic dissections, are discussed. In this report, a case of a male, 40-year-old patient who suffered from spontaneous rupture of undilated abdominal aorta, a manifestation of idiopathic cystic media necrosis (Gsell-Erdheim syndrome), is presented. Spontaneous ruptures of medium-to-large arteries observed in this syndrome are a consequence of elastic fibres degeneration and glucose-amino-glycans (GAG) depositions in the arterial media. Gsell-Erdheim syndrome is also observed in a large portion of spontaneous aortic dissections. Histopathological criteria for the diagnosis of this disease, as well as clinical implications for current treatment, especially endovascular procedures in the aortic dissections, are discussed.
- 29 September 2016
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 22 (1) , 16-19
Open AccessSpontaneous rupture of abdominal aorta — an unusual manifestation of an idiopathic cystic medial necrosis (Gsell-Erdheim syndrome) and literature overview
In this report, a case of a male, 40-year-old patient who suffered from spontaneous rupture of undilated abdominal aorta, a manifestation of idiopathic cystic media necrosis (Gsell-Erdheim syndrome), is presented. Spontaneous ruptures of medium-to-large arteries observed in this syndrome are a consequence of elastic fibres degeneration and glucose-amino-glycans (GAG) depositions in the arterial media. Gsell-Erdheim syndrome is also observed in a large portion of spontaneous aortic dissections. Histopathological criteria for the diagnosis of this disease, as well as clinical implications for current treatment, especially endovascular procedures in the aortic dissections, are discussed. In this report, a case of a male, 40-year-old patient who suffered from spontaneous rupture of undilated abdominal aorta, a manifestation of idiopathic cystic media necrosis (Gsell-Erdheim syndrome), is presented. Spontaneous ruptures of medium-to-large arteries observed in this syndrome are a consequence of elastic fibres degeneration and glucose-amino-glycans (GAG) depositions in the arterial media. Gsell-Erdheim syndrome is also observed in a large portion of spontaneous aortic dissections. Histopathological criteria for the diagnosis of this disease, as well as clinical implications for current treatment, especially endovascular procedures in the aortic dissections, are discussed.
- Open Access
- 8 July 2016
- Published by SAGE Publications in Vascular Medicine
- Vol. 21 (5) , 453-458
Outcomes of accelerated catheter-directed thrombolysis in patients with acute arterial thrombosis
Current intra-arterial catheter-directed thrombolysis (CDT) protocols recommend treatment with small doses of a thrombolytic agent, which excludes patients in need of urgent revascularization. We evaluated the effects of accelerated thrombolysis utilizing increased recombinant tissue plasminogen activator (rt-PA) doses. Forty-one patients with acute, thrombotic limb ischemia (ALI) were treated using accelerated CDT. The treatment consisted of an initial dose of 10 mg rt-PA for 30 minutes followed by a 3-hour course of a continuous intra-arterial 10 mg/hour rt-PA infusion. Simultaneously, intravenous unfractionated heparin (500 IU/hour) was administered. No deaths occurred. Satisfactory lysis was achieved in 37 of the 41 patients (90.2%). All significant underlying lesions were corrected (89.2%). Complications developed in nine patients (22%); the most frequent complication (four patients, 9.8%) was puncture site hematoma. The reintervention rate was 2.6% and 15.4% at the 1 and 6-month follow-ups, respectively. The major amputation rate was 10.3% and 12.8% at the 1 and 6-month follow-ups, respectively. Outflow compromise was adversely related to successful outcome at the 6-month follow-up (p=0.01). In conclusion, this study confirms the effectiveness and safety of the accelerated CDT regimen for treatment of thrombotic ALI at a single center, but requires confirmation in further studies.
- 8 July 2016
- Published by SAGE Publications in Vascular Medicine
- Vol. 21 (5) , 453-458
Open AccessOutcomes of accelerated catheter-directed thrombolysis in patients with acute arterial thrombosis
Current intra-arterial catheter-directed thrombolysis (CDT) protocols recommend treatment with small doses of a thrombolytic agent, which excludes patients in need of urgent revascularization. We evaluated the effects of accelerated thrombolysis utilizing increased recombinant tissue plasminogen activator (rt-PA) doses. Forty-one patients with acute, thrombotic limb ischemia (ALI) were treated using accelerated CDT. The treatment consisted of an initial dose of 10 mg rt-PA for 30 minutes followed by a 3-hour course of a continuous intra-arterial 10 mg/hour rt-PA infusion. Simultaneously, intravenous unfractionated heparin (500 IU/hour) was administered. No deaths occurred. Satisfactory lysis was achieved in 37 of the 41 patients (90.2%). All significant underlying lesions were corrected (89.2%). Complications developed in nine patients (22%); the most frequent complication (four patients, 9.8%) was puncture site hematoma. The reintervention rate was 2.6% and 15.4% at the 1 and 6-month follow-ups, respectively. The major amputation rate was 10.3% and 12.8% at the 1 and 6-month follow-ups, respectively. Outflow compromise was adversely related to successful outcome at the 6-month follow-up (p=0.01). In conclusion, this study confirms the effectiveness and safety of the accelerated CDT regimen for treatment of thrombotic ALI at a single center, but requires confirmation in further studies.
- 1 May 2016
- Published by Hogrefe Publishing Group in Vasa
- Vol. 45 (3) , 213-221
Treatment of acute lower limb ischaemia
Acute lower limb ischaemia poses a major threat to limb survival. For many years surgical thromboembolectomy was the mainstay of treatment. Recent years have brought an endovascular revolution in the management of acute lower limb ischaemia. A wide range of endovascular procedures can nowadays be employed, providing results at least as good as the traditional surgical approach. This paper is an overview of currently utilised endovascular options as well as recent modifications of standard surgical techniques.
- 1 May 2016
- Published by Hogrefe Publishing Group in Vasa
- Vol. 45 (3) , 213-221
Treatment of acute lower limb ischaemia
Acute lower limb ischaemia poses a major threat to limb survival. For many years surgical thromboembolectomy was the mainstay of treatment. Recent years have brought an endovascular revolution in the management of acute lower limb ischaemia. A wide range of endovascular procedures can nowadays be employed, providing results at least as good as the traditional surgical approach. This paper is an overview of currently utilised endovascular options as well as recent modifications of standard surgical techniques.
- Open Access
- 28 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-8
Blood Vessel Matrix Seeded with Cells: A Better Alternative for Abdominal Wall Reconstruction—A Long-Term Study
Purpose. The aim of this study was to present abdominal wall reconstruction using a porcine vascular graft seeded with MSC (mesenchymal stem cells) on rat model.Material and Methods. Abdominal wall defect was prepared in 21 Wistar rats. Acellular porcine-vascular grafts taken from aorta and prepared with Triton X were used. 14 aortic grafts were implanted in place, of which 7 grafts were seeded with rat MSC cells (Group I), and 7 were acellular grafts (Group II). As a control, 7 standard polypropylene meshes were used for defect augmentation (Group III). The assessment method was performed by HE and CD31 staining after 6 months. The mechanical properties have been investigated by Zwick&Roell Z0.5.Results. The strongest angiogenesis and lowest inflammatory response were observed in Group I. Average capillaries density was 2.75, 0.75, and 1.53 and inflammatory effect was 0.29, 1.39, and 2.72 for Groups I, II, and III, respectively. The means of mechanical properties were,, and N/cm in Groups I and II and control, respectively.Conclusions. Cell-seeded grafts have better mechanical properties than acellular grafts but worse than polypropylene mesh. Cells improved mechanical and physiological properties of decellularized natural scaffolds.- 28 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-8
Open AccessBlood Vessel Matrix Seeded with Cells: A Better Alternative for Abdominal Wall Reconstruction—A Long-Term Study
Purpose. The aim of this study was to present abdominal wall reconstruction using a porcine vascular graft seeded with MSC (mesenchymal stem cells) on rat model.Material and Methods. Abdominal wall defect was prepared in 21 Wistar rats. Acellular porcine-vascular grafts taken from aorta and prepared with Triton X were used. 14 aortic grafts were implanted in place, of which 7 grafts were seeded with rat MSC cells (Group I), and 7 were acellular grafts (Group II). As a control, 7 standard polypropylene meshes were used for defect augmentation (Group III). The assessment method was performed by HE and CD31 staining after 6 months. The mechanical properties have been investigated by Zwick&Roell Z0.5.Results. The strongest angiogenesis and lowest inflammatory response were observed in Group I. Average capillaries density was 2.75, 0.75, and 1.53 and inflammatory effect was 0.29, 1.39, and 2.72 for Groups I, II, and III, respectively. The means of mechanical properties were,, and N/cm in Groups I and II and control, respectively.Conclusions. Cell-seeded grafts have better mechanical properties than acellular grafts but worse than polypropylene mesh. Cells improved mechanical and physiological properties of decellularized natural scaffolds. - 1 August 2014
- Vol. 33 (4) , 309-15
The influence of carotid endarterectomy on cerebral blood flow in significant carotid stenosis-perfusion computed tomography study.
Carotid endarterectomy (CEA) is well recognized procedure in the treatment of patients with significant symptomatic internal carotid artery (ICA) stenosis. Operation reconstitutes physiologic blood flow in the ICA. The influence of CEA on cerebral perfusion (CP) is not well established. Some data suggest increased CP after stenosis correction however evidence in post-endarterectomy patients is scarce. Our aim was to investigate the influence of CEA in patients with symptomatic carotid stenosis on CP parameters by means of perfusion computed tomography (PCT). Thirty-four patients with symptomatic severe carotid stenosis qualified for CEA were included. The baseline PCT of the brain according to standardized protocol was performed within 3 weeks prior to surgical procedure. The follow-up PCT was performed between 30-60th day postop. The following perfusion parameters were analyzed: cerebral blood flow (CBF), cerebral blood volume (CBV), peak enhancement intensity (PEI) and time to peak (TTP). Pre- and postoperative average values of these parameters were compared. No death/stroke occurred in the investigated group. Mean preoperative total CBF was 66.2 mL/100 g/min and was not dependent on the degree of the carotid stenosis or the presence of contralateral carotid artery stenosis. Mean postoperative total CBF was significantly lower (61.8 mL/100g/min, P<0.05). No significant changes in PEI, TTP and CBV were observed PCT of the brain reveals that CEA in patients with symptomatic carotid stenosis decreased total CBF especially in the contralateral hemisphere.
- 1 August 2014
- Vol. 33 (4) , 309-15
The influence of carotid endarterectomy on cerebral blood flow in significant carotid stenosis-perfusion computed tomography study.
Carotid endarterectomy (CEA) is well recognized procedure in the treatment of patients with significant symptomatic internal carotid artery (ICA) stenosis. Operation reconstitutes physiologic blood flow in the ICA. The influence of CEA on cerebral perfusion (CP) is not well established. Some data suggest increased CP after stenosis correction however evidence in post-endarterectomy patients is scarce. Our aim was to investigate the influence of CEA in patients with symptomatic carotid stenosis on CP parameters by means of perfusion computed tomography (PCT). Thirty-four patients with symptomatic severe carotid stenosis qualified for CEA were included. The baseline PCT of the brain according to standardized protocol was performed within 3 weeks prior to surgical procedure. The follow-up PCT was performed between 30-60th day postop. The following perfusion parameters were analyzed: cerebral blood flow (CBF), cerebral blood volume (CBV), peak enhancement intensity (PEI) and time to peak (TTP). Pre- and postoperative average values of these parameters were compared. No death/stroke occurred in the investigated group. Mean preoperative total CBF was 66.2 mL/100 g/min and was not dependent on the degree of the carotid stenosis or the presence of contralateral carotid artery stenosis. Mean postoperative total CBF was significantly lower (61.8 mL/100g/min, P<0.05). No significant changes in PEI, TTP and CBV were observed PCT of the brain reveals that CEA in patients with symptomatic carotid stenosis decreased total CBF especially in the contralateral hemisphere.
- Open Access
- 28 February 2014
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 23 (1) , 135-142
Synthetic Implants in Hernia Surgery
Abdominal wall hernia correction is one of the most common surgical procedures. 85,000 hernia operations are performed in Poland each year. Modern techniques of abdominal wall reconstruction utilize surgical implants for fascial defect closure. In the 70s and the 80s of the last century, these techniques gained widespread acceptance among surgeons. Significant improvement of results in terms of recurrences was observed. Treatment of large abdominal wall defects became possible. Three types of surgical implants were developed early: polipropylene (PP), poliethylene (PE) and politetrafluoroethylene (PTFE). Unfortunately, negative effects of implanted material soon became apparent. Excessive native tissues inflammatory response to the implanted material, leading to multiple complications was observed. Recurrences due to fibrosis, chronic regional pain, stiffness of the operation site, intestinal adhesions and fistulas, infertility and infections were reported. In some cases the use of standard synthetic implant was contraindicated. Analyzing drawbacks of the standard hernia implants, the medical industry developed new materials to improve treatment results. The most popular, currently utilized synthetic materials, are presented in this review in the context of clinical results.
- 28 February 2014
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 23 (1) , 135-142
Open AccessSynthetic Implants in Hernia Surgery
Abdominal wall hernia correction is one of the most common surgical procedures. 85,000 hernia operations are performed in Poland each year. Modern techniques of abdominal wall reconstruction utilize surgical implants for fascial defect closure. In the 70s and the 80s of the last century, these techniques gained widespread acceptance among surgeons. Significant improvement of results in terms of recurrences was observed. Treatment of large abdominal wall defects became possible. Three types of surgical implants were developed early: polipropylene (PP), poliethylene (PE) and politetrafluoroethylene (PTFE). Unfortunately, negative effects of implanted material soon became apparent. Excessive native tissues inflammatory response to the implanted material, leading to multiple complications was observed. Recurrences due to fibrosis, chronic regional pain, stiffness of the operation site, intestinal adhesions and fistulas, infertility and infections were reported. In some cases the use of standard synthetic implant was contraindicated. Analyzing drawbacks of the standard hernia implants, the medical industry developed new materials to improve treatment results. The most popular, currently utilized synthetic materials, are presented in this review in the context of clinical results.